BEGIN:VCALENDAR
PRODID:-//ics 70.9054//EN
VERSION:2.0
BEGIN:VTIMEZONE
TZID:Europe/Paris
X-LIC-LOCATION:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:PDT
DTSTART:19700308T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:PST
DTSTART:19701101T020000
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTAMP;TZID=Europe/Paris:20260906T040919
SUMMARY:WORKSHOP : Normal and pathological brain ageing:   from systems biology to the clinic
DTSTART;TZID=Europe/Paris:20161019T000000
DTEND;TZID=Europe/Paris:20161019T235959
UID:20161019162
DESCRIPTION:Alzheimer’s disease is characterized by diminishing memory and thinking skills, affecting as many as 8 million  Europeans, most over the age of 60. The causes of Alzheimer’s disease are still largely unknown, though they are likely a combination of genetic, environmental and other factors.As part of ongoing research to better understand the complexities of the human brain, European-funded FP7-HEALTH AgedBrainSYSBIO consortium (on systems biology, synapse and ageing) is embarking on efforts to unravel molecular mechanisms involved in brain functioning both in normal conditions and during ageing.We expect that this meeting will generate novel interactions between leading groups in the field. Because of the increasing interest in ageing-related diseases such as neuropathologies, we expect the symposium to gather up to 150 participants. This symposium will bring together clinicians, biologists, bioinformaticians, statisticians, who will present the latest advances in the field of neuroscience, taking advantage of state-of-the-art approaches provided by omics-biotechnologies, supercomputers, neuroimaging, amongst others.The meeting will survey recent discoveries in the field of normal and pathological brain ageing: from systems biology to the clinic.
LOCATION:Paris, France
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR